Podcast charts
Published by Abtrace
We talk about all things Health Care, Health Tech and Abtrace
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
In Episode 2, Dr Amina Siddiqui talks to Shirin Alwash, a Senior Digital Pharmacist at Abtrace. She shares her journey from traditional pharmacy to health tech, offering insights into how AI-driven optimisation is transforming medication management and care navigation in primary care. Shirin discusses how Abtrace enhances prescribing accuracy, automates clinical workflows, and supports data-led decision-making, ensuring patients receive the right treatment at the right time. She highlights the impact of pharmacists in improving patient safety, reducing medication errors, and streamlining practice efficiency. Discover how Abtrace is revolutionising medicines optimisation, helping clinicians work smarter, not harder, and driving the NHS’s transition to a more proactive, data-driven healthcare system.
In Episode 1, Dr Amina Siddiqui talks to Dr Simon Doyle, an experienced GP. He shares his journey into health tech and his firsthand experience with Abtrace. Discover how this tool transforms primary care through automation, simplifies daily workflows, and enhances patient safety, achieving impressive results like a 73% completion rate for blood pressure recalls in just four weeks. Dr. Doyle highlights Abtrace’s ease of use, proactive case-finding, and impact on population health management, aligning with the NHS's shift from analogue to digital care.
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed November 4, 2026.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.